CoVLP (brand name Covifenz) was a COVID-19 vaccine developed by Medicago in Canada and GlaxoSmithKline (GSK). The product and Medicago, Inc. were owned...
18 KB (1,643 words) - 10:03, 8 November 2023
List of COVID-19 vaccine authorizations (section CoVLP)
Emergency (2) Belarus Cuba Travel-only Guyana Malaysia New Zealand Turkey CoVLP is a virus-like particle vaccine grown in an Australian weed, Nicotiana...
319 KB (19,375 words) - 22:21, 17 July 2024
associated illnesses. The lead COVID-19 vaccine candidate, CoVLP, by Medicago, was a coronavirus VLP grown in the Australian weed, Nicotiana benthamiana. Medicago...
18 KB (1,598 words) - 04:33, 11 February 2024
Virus-like particle (redirect from VLPs)
Virus-like particles (VLPs) are molecules that closely resemble viruses, but are non-infectious because they contain no viral genetic material. They can...
22 KB (2,535 words) - 21:43, 4 May 2024
February 2022, Health Canada authorised use of the COVID-19 vaccine called CoVLP (brand name Covifenz) developed from N. benthamiana for preventing infection...
8 KB (812 words) - 13:05, 3 June 2024
COVID-19 vaccine (redirect from SARS-CoV-2 vaccine)
acquired immunity against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the virus that causes coronavirus disease 2019 (COVID‑19). Prior to the...
199 KB (22,726 words) - 08:47, 6 August 2024
Soberana 02, Soberana Plus, V-01, and ZF2001. one virus-like particle vaccine: CoVLP As of June 2022[update], 353 vaccine candidates are in various stages of...
95 KB (18,965 words) - 15:46, 23 June 2024
Pakse International Airport (IATA: PKZ, ICAO: VLPS) is one of the few international airports in Laos. Pakse is the former southern capital city of the...
4 KB (260 words) - 08:28, 31 July 2024
recombinant DNA or recombinant viruses to produce virus-like particles (VLPs) in the person being vaccinated. Formed in 2001 in Atlanta, Georgia, the...
12 KB (1,353 words) - 04:18, 18 July 2024
Bacteriophage AP205 (section SARS-CoV-2)
receptor binding domain of the SARS-CoV-2 spike protein to invoke an immune response in mice. A stable AP205 VLP was designed by using a linker to fuse...
33 KB (4,020 words) - 09:31, 18 June 2024